Tocilizumab demonstrates superiority in decreasing C-reactive protein levels in hospitalized COVID-19 patients, compared to standard care treatment alone.
Article in Microbiology Spectrum (April 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in Microbiology Spectrum (April 2024)
Article in Scientific Reports (November 2023)
Preprint in Research Square (August 2023)